Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCFinancial_Report.xls
10-Q - QUARTERLY REPORT - VENTRUS BIOSCIENCES INCv326006_10q.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR6.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR8.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR7.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR1.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR2.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR9.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR18.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR17.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR22.htm
EX-31.1 - CERTIFICATION - VENTRUS BIOSCIENCES INCv326006_ex31-1.htm
EX-32.1 - CERTIFICATION - VENTRUS BIOSCIENCES INCv326006_ex32-1.htm
EX-31.2 - CERTIFICATION - VENTRUS BIOSCIENCES INCv326006_ex31-2.htm
EX-32.2 - CERTIFICATION - VENTRUS BIOSCIENCES INCv326006_ex32-2.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR5.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR13.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR19.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR11.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR15.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR14.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR12.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR20.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR23.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR16.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR21.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR3.htm
XML - IDEA: XBRL DOCUMENT - VENTRUS BIOSCIENCES INCR10.htm
v2.4.0.6
CONDENSED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended 84 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Operating expenses:          
Research and development $ 4,188,127 $ 3,667,179 $ 16,772,777 $ 7,737,523 $ 56,302,020
General and administrative 1,182,176 1,878,718 4,265,889 7,376,738 18,510,957
Loss from operations (5,370,303) (5,545,897) (21,038,666) (15,114,261) (74,812,977)
Other income (expense)          
Interest income 14,906 28,423 39,345 47,880 135,398
Interest expense:          
Beneficial conversion feature 0 0 0 0 (6,001,496)
Amortization of debt discount and warrants 0 (253,302) 0 (302,327) (2,865,758)
Interest expense 0 (30,605) 0 (116,664) (4,983,572)
Interest Expense 0 (283,907) 0 (418,991) (13,850,826)
Net loss $ (5,355,397) $ (5,801,381) $ (20,999,321) $ (15,485,372) $ (88,528,405)
Basic and diluted net loss per common share $ (0.41) $ (0.50) $ (1.66) $ (1.79)  
Weighted average common shares outstanding basic and diluted 12,933,340 11,616,786 12,657,538 8,672,858